Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 05 apr 2016 - 17:34

Statutaire naam Vivoryon Therapeutics N.V.

Titel Probiodrug to hold its Ordinary General Meeting of Shareholders on May 19, 2016

Bericht Probiodrug to hold its Ordinary General Meeting of Shareholders on May 19, 2016 HALLE/SAALE, Germany, 05 April 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), has the honour to invite its shareholders to its ordinary general meeting of shareholders to be held on Thursday, 19 May 2016 at 11.00 am (CEST), in the Leonardo Royal Hotel Berlin Alexanderplatz, Otto-Braun-Straße 90, 10249 Berlin, Germany.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201604050000000014_Probiodrug to hold its Ordinary General Meeting of Shareholders on May 19, 2016.pdf (opens in a new window)

Datum laatste update: 21 december 2025